250 related articles for article (PubMed ID: 19615803)
1. The uremic retention solute p-cresyl sulfate and markers of endothelial damage.
Meijers BK; Van Kerckhoven S; Verbeke K; Dehaen W; Vanrenterghem Y; Hoylaerts MF; Evenepoel P
Am J Kidney Dis; 2009 Nov; 54(5):891-901. PubMed ID: 19615803
[TBL] [Abstract][Full Text] [Related]
2. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
Dou L; Bertrand E; Cerini C; Faure V; Sampol J; Vanholder R; Berland Y; Brunet P
Kidney Int; 2004 Feb; 65(2):442-51. PubMed ID: 14717914
[TBL] [Abstract][Full Text] [Related]
3. P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro.
Cerini C; Dou L; Anfosso F; Sabatier F; Moal V; Glorieux G; De Smet R; Vanholder R; Dignat-George F; Sampol J; Berland Y; Brunet P
Thromb Haemost; 2004 Jul; 92(1):140-50. PubMed ID: 15213855
[TBL] [Abstract][Full Text] [Related]
4. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
[TBL] [Abstract][Full Text] [Related]
5. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P
Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453
[TBL] [Abstract][Full Text] [Related]
6. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
[TBL] [Abstract][Full Text] [Related]
7. Does uremia cause vascular dysfunction?
Brunet P; Gondouin B; Duval-Sabatier A; Dou L; Cerini C; Dignat-George F; Jourde-Chiche N; Argiles A; Burtey S
Kidney Blood Press Res; 2011; 34(4):284-90. PubMed ID: 21691132
[TBL] [Abstract][Full Text] [Related]
8. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin.
Meijers BK; De Preter V; Verbeke K; Vanrenterghem Y; Evenepoel P
Nephrol Dial Transplant; 2010 Jan; 25(1):219-24. PubMed ID: 19692415
[TBL] [Abstract][Full Text] [Related]
9. Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.
Poesen R; Evenepoel P; de Loor H; Kuypers D; Augustijns P; Meijers B
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1136-1144. PubMed ID: 27084876
[TBL] [Abstract][Full Text] [Related]
10. Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption.
Meijers BK; Weber V; Bammens B; Dehaen W; Verbeke K; Falkenhagen D; Evenepoel P
Artif Organs; 2008 Mar; 32(3):214-9. PubMed ID: 18201285
[TBL] [Abstract][Full Text] [Related]
11. Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction.
Jourde-Chiche N; Dou L; Cerini C; Dignat-George F; Brunet P
Semin Dial; 2011; 24(3):327-37. PubMed ID: 21682773
[TBL] [Abstract][Full Text] [Related]
12. Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate.
Viaene L; Annaert P; de Loor H; Poesen R; Evenepoel P; Meijers B
Biopharm Drug Dispos; 2013 Apr; 34(3):165-75. PubMed ID: 23300093
[TBL] [Abstract][Full Text] [Related]
13. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.
Bammens B; Evenepoel P; Keuleers H; Verbeke K; Vanrenterghem Y
Kidney Int; 2006 Mar; 69(6):1081-7. PubMed ID: 16421516
[TBL] [Abstract][Full Text] [Related]
14. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
[TBL] [Abstract][Full Text] [Related]
15. The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro.
Faure V; Cerini C; Paul P; Berland Y; Dignat-George F; Brunet P
Int Immunol; 2006 Oct; 18(10):1453-9. PubMed ID: 16954166
[TBL] [Abstract][Full Text] [Related]
16. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
[TBL] [Abstract][Full Text] [Related]
17. Free p-cresol sulfate is associated with survival and function of vascular access in chronic hemodialysis patients.
Chen TC; Wang CY; Hsu CY; Wu CH; Kuo CC; Wang KC; Yang CC; Wu MT; Chuang FR; Lee CT
Kidney Blood Press Res; 2012; 35(6):583-8. PubMed ID: 22922348
[TBL] [Abstract][Full Text] [Related]
18. Uremic toxin development in living kidney donors: a longitudinal study.
Rossi M; Campbell KL; Johnson DW; Stanton T; Haluska BA; Hawley CM; Dimeski G; McWhinney BC; Ungerer JP; Kaisar OM; Isbel NM
Transplantation; 2014 Mar; 97(5):548-54. PubMed ID: 24162249
[TBL] [Abstract][Full Text] [Related]
19. Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin.
Watanabe H; Noguchi T; Miyamoto Y; Kadowaki D; Kotani S; Nakajima M; Miyamura S; Ishima Y; Otagiri M; Maruyama T
Drug Metab Dispos; 2012 Jul; 40(7):1423-8. PubMed ID: 22513409
[TBL] [Abstract][Full Text] [Related]
20. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
